LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 42.67 | 771.67 | 5003 | 5155 | 0.9704 | 0.9782 | MN20160304_L01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 44.89 | 771.67 | 4406 | 5541 | 0.7951 | 0.8451 | MN20160304_L01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 44.89 | 771.67 | 5291 | 5541 | 0.9548 | 0.9677 | MN20160304_L01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 47.11 | 771.67 | 4648 | 5941 | 0.7823 | 0.8400 | MN20160304_L01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 47.11 | 771.67 | 5462 | 5941 | 0.9193 | 0.9437 | MN20160304_L01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 49.33 | 771.67 | 5004 | 6392 | 0.7828 | 0.8457 | MN20160304_L01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 49.33 | 771.67 | 5938 | 6392 | 0.9289 | 0.9522 | MN20160304_L01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 51.55 | 771.67 | 5281 | 6829 | 0.7732 | 0.8430 | MN20160304_L01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 51.55 | 771.67 | 6228 | 6829 | 0.9119 | 0.9422 | MN20160304_L01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 53.77 | 771.67 | 5637 | 7256 | 0.7768 | 0.8497 | MN20160304_L01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 53.77 | 771.67 | 6684 | 7256 | 0.9211 | 0.9498 | MN20160304_L01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 55.99 | 771.67 | 5899 | 7690 | 0.7671 | 0.8464 | MN20160304_L01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 55.99 | 771.67 | 7092 | 7690 | 0.9222 | 0.9518 | MN20160304_L01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 58.21 | 771.67 | 6228 | 8085 | 0.7703 | 0.8518 | MN20160304_L01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 58.21 | 771.67 | 7563 | 8085 | 0.9354 | 0.9610 | MN20160304_L01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 60.44 | 771.67 | 6587 | 8530 | 0.7722 | 0.8563 | MN20160304_L01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 60.44 | 771.67 | 7977 | 8530 | 0.9351 | 0.9617 | MN20160304_L01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 62.66 | 771.67 | 6841 | 8978 | 0.7619 | 0.8522 | MN20160304_L01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 62.66 | 771.67 | 8358 | 8978 | 0.9309 | 0.9600 | MN20160304_L01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 64.88 | 771.67 | 7130 | 9447 | 0.7547 | 0.8502 | MN20160304_L01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 64.88 | 771.67 | 8788 | 9447 | 0.9302 | 0.9604 | MN20160304_L01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 67.10 | 771.67 | 7497 | 9800 | 0.7650 | 0.8591 | MN20160304_L01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 67.10 | 771.67 | 9143 | 9800 | 0.9329 | 0.9625 | MN20160304_L01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 69.32 | 771.67 | 7834 | 10212 | 0.7671 | 0.8627 | MN20160304_L01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 69.32 | 771.67 | 9508 | 10212 | 0.9311 | 0.9620 | MN20160304_L01 | M13 |